These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7161958)

  • 1. Evidence for the presence of D2 and 5-HT2 receptors in the human prefrontal cortex.
    Mita T; Kuno T; Nakai H; Tanaka C
    Jpn J Pharmacol; 1982 Dec; 32(6):1027-32. PubMed ID: 7161958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ; Seeman P
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states.
    George SR; Watanabe M; Seeman P
    J Neurochem; 1985 Apr; 44(4):1168-77. PubMed ID: 2579204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
    Wilmot CA; Szczepanik AM
    Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two classes of [3H]spiperone binding sites in bovine neurohypophysis: D-2 receptors and putative 5-HT2 receptors.
    Treiman M; Andersen PH
    J Recept Res; 1989; 9(4-5):297-312. PubMed ID: 2574236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Labelling of D2-dopaminergic and 5-HT2-serotonergic binding sites in human trophoblastic cells using [3H]-spiperone.
    Vaillancourt C; Petit A; Gallo-Payet N; Bellabarba D; Lehoux JG; Bélisle S
    J Recept Res; 1994 Jan; 14(1):11-22. PubMed ID: 8158579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.
    Niznik HB; Grigoriadis DE; Pri-Bar I; Buchman O; Seeman P
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):333-43. PubMed ID: 2863760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol.
    Altar CA; Kim H; Marshall JF
    J Pharmacol Exp Ther; 1985 May; 233(2):527-38. PubMed ID: 3889277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the kinetics of the interaction of spiperone with binding sites on human mononuclear cells: existence of a heterogeneous population of spiperone binding sites.
    Zaitsev SV; Koshkin AA; Izumrudova II; Varfolomeev SD
    J Neuroimmunol; 1992 Feb; 36(2-3):225-9. PubMed ID: 1732283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of N-alkylation on the affinities of analogues of spiperone for dopamine D2 and serotonin 5-HT2 receptors.
    Mach RH; Jackson JR; Luedtke RR; Ivins KJ; Molinoff PB; Ehrenkaufer RL
    J Med Chem; 1992 Feb; 35(3):423-30. PubMed ID: 1531364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo binding of (E)- and (Z)-N-(iodoallyl)spiperone to dopamine D2 and serotonin 5-HT2 neuroreceptors.
    Lever JR; Scheffel UA; Stathis M; Musachio JL; Wagner HN
    Life Sci; 1990; 46(26):1967-76. PubMed ID: 2362552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the existence of receptor--receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides.
    Fuxe K; Agnati LF; Benfenati F; Celani M; Zini I; Zoli M; Mutt V
    J Neural Transm Suppl; 1983; 18():165-79. PubMed ID: 6192208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of dopaminergic receptors in the primate cerebral cortex: quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390.
    Lidow MS; Goldman-Rakic PS; Gallager DW; Rakic P
    Neuroscience; 1991; 40(3):657-71. PubMed ID: 2062437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of [3H]haloperidol to dopamine D2 receptors in the rat striatum.
    Tsuchihashi H; Sasaki T; Kojima S; Nagatomo T
    J Pharm Pharmacol; 1992 Nov; 44(11):911-4. PubMed ID: 1361536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 125I-Spiperone: a novel ligand for D2 dopamine receptors.
    Gundlach AL; Largent BL; Snyder SH
    Life Sci; 1984 Nov; 35(19):1981-8. PubMed ID: 6149442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of subchronic treatment with various neuroleptic agents on serotonin2 receptors in rat cerebral cortex.
    Andree TH; Mikuni M; Tong CY; Koenig JI; Meltzer HY
    J Neurochem; 1986 Jan; 46(1):191-7. PubMed ID: 2866233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D2 dopamine receptors in the rat prefrontal cortex: characterization and alteration by stress.
    MacLennan AJ; Pelleymounter MA; Atmadja S; Jakubovic A; Maier SF; Fibiger HC
    Brain Res; 1989 Jan; 477(1-2):300-7. PubMed ID: 2522809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
    Leysen JE; Gommeren W
    J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3H-spiperone labels sigma receptors, not dopamine D2 receptors, in rat and human lymphocytes.
    Coccini T; Manzo L; Costa LG
    Immunopharmacology; 1991; 22(2):93-105. PubMed ID: 1662188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo [3H]spiperone binding to the rat hippocampal formation: involvement of dopamine receptors.
    Bischoff S; Bittiger H; Krauss J
    Eur J Pharmacol; 1980 Dec; 68(3):305-15. PubMed ID: 7202494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.